Old Web
English
Sign In
Acemap
>
authorDetail
>
Harrie Rila
Harrie Rila
Bristol-Myers Squibb
Medicine
cost effectiveness
Cost-effectiveness analysis
Emergency medicine
Apixaban
3
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings
2019
PLOS ONE
Lisa A. de Jong
Jessie Groeneveld
J. Stevanovic
Harrie Rila
Robert G. Tieleman
Menno V. Huisman
Maarten J. Postma
Marinus van Hulst
Show All
Source
Cite
Save
Citations (17)
PCV30 COST-EFFECTIVENESS OF NOACS IN PATIENTS WITH ATRIAL FIBRILLATION: USING REAL-WORLD DATA FOR EXTERNAL VALIDATION
2019
Value in Health
L. de Jong
J Groeneveld
J. Stevanovic
Harrie Rila
Robert G. Tieleman
Menno V. Huisman
Maarten J. Postma
M. van Hulst
Show All
Source
Cite
Save
Citations (0)
Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects
2018
BMJ Open
Lisa A. de Jong
Judith J. Gout-Zwart
J. Stevanovic
Harrie Rila
Mike Koops
Menno V. Huisman
Maarten J. Postma
Show All
Source
Cite
Save
Citations (2)
1